DE69706406D1 - 5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente - Google Patents

5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente

Info

Publication number
DE69706406D1
DE69706406D1 DE69706406T DE69706406T DE69706406D1 DE 69706406 D1 DE69706406 D1 DE 69706406D1 DE 69706406 T DE69706406 T DE 69706406T DE 69706406 T DE69706406 T DE 69706406T DE 69706406 D1 DE69706406 D1 DE 69706406D1
Authority
DE
Germany
Prior art keywords
derivatives
eüä1
dihydrodibenz
oxazepine
medicines containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69706406T
Other languages
English (en)
Other versions
DE69706406T2 (de
Inventor
Yuji Tanaka
Keiji Misumi
Yoshinari Kawakami
Masahiko Moriguchi
Kazuyoshi Takahashi
Hiroki Okamoto
Toshiaki Kamisaki
Kimihiro Inoue
Makoto Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of DE69706406D1 publication Critical patent/DE69706406D1/de
Application granted granted Critical
Publication of DE69706406T2 publication Critical patent/DE69706406T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69706406T 1996-03-11 1997-03-11 5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente Expired - Fee Related DE69706406T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8310496 1996-03-11
PCT/JP1997/000754 WO1997033885A1 (fr) 1996-03-11 1997-03-11 DERIVES DE 5,11-DIHYDRODIBENZ[b,e] [1,4]OXAZEPINE, ET COMPOSITIONS MEDICAMENTEUSES LES COMPORTANT

Publications (2)

Publication Number Publication Date
DE69706406D1 true DE69706406D1 (de) 2001-10-04
DE69706406T2 DE69706406T2 (de) 2002-04-18

Family

ID=13792896

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69706406T Expired - Fee Related DE69706406T2 (de) 1996-03-11 1997-03-11 5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente

Country Status (16)

Country Link
US (2) US6127361A (de)
EP (1) EP0889043B1 (de)
JP (1) JP3127469B2 (de)
KR (1) KR100344331B1 (de)
CN (1) CN1085209C (de)
AT (1) ATE204871T1 (de)
AU (1) AU704521B2 (de)
BR (1) BR9707962A (de)
CA (1) CA2261271C (de)
DE (1) DE69706406T2 (de)
ES (1) ES2159843T3 (de)
NO (1) NO310976B1 (de)
PT (1) PT889043E (de)
TW (1) TW479057B (de)
WO (1) WO1997033885A1 (de)
ZA (1) ZA972038B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69811520T2 (de) 1997-09-10 2003-12-11 Ajinomoto Kk 5,11-DIHYDROBENZ[b,e][1,4]OXAZEPIN-DERIVATE UND DIESE ENTHALTENDE MEDIZINISCHE ZUBEREITUNGEN
EP1471060A1 (de) 1999-01-08 2004-10-27 Ajinomoto Co., Inc. 5,11-Dihydrodibenzo[b,e][1,4]-oxazepin-Verbindungen als Calciumkanal Antagonisten
AU6868900A (en) * 1999-09-03 2001-04-10 Ajinomoto Co., Inc. Novel processes for preparing oxazepine derivatives
AU2001217359A1 (en) * 2000-12-11 2002-06-24 Ajinomoto Co., Inc. Novel crystals of oxazepine derivatives and process for the production thereof
WO2002096891A1 (fr) 2001-05-30 2002-12-05 Ajinomoto Co.,Inc. Derives de dihydrodiaryloxazepine, et medicaments contenant ces derives
JP2005343791A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc 消化管疾患を治療するための医薬組成物
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
CN104016937B (zh) * 2014-05-09 2016-12-07 中科院广州化学有限公司 一种n-芳基氧氮杂卓酮类化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912303D0 (en) * 1989-05-27 1989-07-12 Pfizer Ltd Therapeutic agents
AU2669992A (en) * 1991-11-05 1993-06-07 G.D. Searle & Co. 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists
EP1404359A2 (de) * 2000-12-07 2004-04-07 Board Of Regents, The University Of Texas System Behandlungsverfahren mit menschlichem mda-7

Also Published As

Publication number Publication date
KR19990087655A (ko) 1999-12-27
ES2159843T3 (es) 2001-10-16
US6127361A (en) 2000-10-03
WO1997033885A1 (fr) 1997-09-18
TW479057B (en) 2002-03-11
AU704521B2 (en) 1999-04-22
KR100344331B1 (ko) 2002-12-05
AU2233597A (en) 1997-10-01
EP0889043A4 (de) 1999-07-21
US6436922B1 (en) 2002-08-20
BR9707962A (pt) 1999-07-27
CN1085209C (zh) 2002-05-22
EP0889043B1 (de) 2001-08-29
NO310976B1 (no) 2001-09-24
NO984162D0 (no) 1998-09-10
JP3127469B2 (ja) 2001-01-22
CA2261271A1 (en) 1997-09-18
ATE204871T1 (de) 2001-09-15
CN1213371A (zh) 1999-04-07
CA2261271C (en) 2003-09-16
PT889043E (pt) 2002-02-28
NO984162L (no) 1998-11-05
DE69706406T2 (de) 2002-04-18
ZA972038B (en) 1997-09-17
EP0889043A1 (de) 1999-01-07

Similar Documents

Publication Publication Date Title
DE69604653D1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
BR1100987A (pt) Composto, composição farmacêutica da matéria, e, composição veterinária
BR9904998A (pt) Derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico
BR9811818A (pt) Uso de um composto, composto, e, composição farmacêutica
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
NO20014925D0 (no) Farmasöytiske forbindelser
TR200001906T2 (tr) Koks-Inhibitörleri olarak 2,3-ikameli indol bileşikleri.
ATE259823T1 (de) Tricyclische erythromycinderivate
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
DE69706406T2 (de) 5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
ES2151698T3 (es) Nuevos derivados de 6-hidroxi y 6-oxo-androstan activos sobre el sistema cardiovascular y composiciones farmaceuticas que los contienen.
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
ATE140458T1 (de) Imidazole derivate und diese enthaltende arzneimittel
DK1073447T3 (da) N1-modificerede glycopeptider
ES2149193T3 (es) Compuestos heterociclicos sustituidos con alquilo.
DE69811520T2 (de) 5,11-DIHYDROBENZ[b,e][1,4]OXAZEPIN-DERIVATE UND DIESE ENTHALTENDE MEDIZINISCHE ZUBEREITUNGEN
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE69403110D1 (de) Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen
EP1142884A4 (de) Oxazepin derivate und drogen die diese enthalten
IT1282289B1 (it) 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare,
IT1269545B (it) Derivati idantoinici

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee